These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2087083

  • 1. [Chylomicronemia syndrome--pathophysiology, clinical aspects and therapy].
    Klör HU.
    Klin Wochenschr; 1990; 68 Suppl 22():68-75. PubMed ID: 2087083
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chylomicronemia syndrome.
    Chait A, Brunzell JD.
    Adv Intern Med; 1992; 37():249-73. PubMed ID: 1557997
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A, Koch H, Haberbosch W, Fellin R, Postiglione A, Augustin J.
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract] [Full Text] [Related]

  • 5. Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management.
    Brown WV, Goldberg I, Duell B, Gaudet D.
    J Clin Lipidol; 2018; 12(2):254-263. PubMed ID: 29534878
    [Abstract] [Full Text] [Related]

  • 6. [Dietary modification of the postprandial phase].
    Canzler H.
    Klin Wochenschr; 1990; 68 Suppl 22():76-82. PubMed ID: 2087085
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Familial chylomicronemia syndrome.
    Mohandas MK, Jemila J, Ajith Krishnan AS, George TT.
    Indian J Pediatr; 2005 Feb; 72(2):181. PubMed ID: 15758547
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion.
    Santos RD, Lorenzatti A, Corral P, Nogueira JP, Cafferata AM, Aimone D, Lourenço CM, Izar MC, Lima JG, Lottenberg AM, Alonso R, Garay K, Morales AR, Vargas-Uricoechea H, Peña CAC, Roman-González A.
    J Clin Lipidol; 2021 Feb; 15(5):620-624. PubMed ID: 34920815
    [Abstract] [Full Text] [Related]

  • 14. Familial chylomicronemia in a nine months old infant.
    Lone SW, Imdad A, Billoo AG.
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):655-6. PubMed ID: 18940129
    [Abstract] [Full Text] [Related]

  • 15. [Hyperlipoproteinemia type I].
    Bustos P, Fernández E, Radrigán E.
    Rev Chil Pediatr; 1987 Oct; 58(6):481-4. PubMed ID: 3506219
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)].
    Bakker HD, Abeling NG, Rammeloo JA, Jansen H, van Gennip AH.
    Ned Tijdschr Geneeskd; 1985 Apr 06; 129(14):642-5. PubMed ID: 3990858
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD, Hazzard WR, Porte D, Bierman EL.
    J Clin Invest; 1973 Jul 06; 52(7):1578-85. PubMed ID: 4352459
    [Abstract] [Full Text] [Related]

  • 19. The molecular basis of familial chylomicronemia.
    Ameis D, Schotz C, Greten H.
    Z Gastroenterol Verh; 1991 Mar 06; 26():102-3. PubMed ID: 1714114
    [No Abstract] [Full Text] [Related]

  • 20. [Genetically-induced functional disorders of lipolytic enzymes and their effect on plasma lipoproteins].
    Greten H.
    Verh Dtsch Ges Inn Med; 1986 Mar 06; 92():402. PubMed ID: 3811540
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.